tradingkey.logo
tradingkey.logo
Search

Cytek Biosciences Inc

CTKB
Add to Watchlist
4.220USD
-0.090-2.09%
Close 07-31 16:00ETQuotes delayed by 15 min
544.98MMarket Cap
LossP/E TTM

Cytek Biosciences Inc

4.220
-0.090-2.09%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-2.09%

5 Days

-5.38%

1 Month

-8.06%

6 Months

-18.22%

Year to Date

-16.44%

1 Year

+15.93%

Key Figures
4.280Open
4.310High
608.89KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.47%Turnover Ratio
4.310Prev. Close
4.135Low
1.68MTurnover
LossP/E Static
1.59P/B
0.00%Div Yield TTM
-15.89%ROA
6.18052wk High
1.03Volume Ratio
-6.02MNet Profit
128.55MShares
-0.5786EPS TTM
1.19Beta
-20.93%ROE
2.46052wk Low
4.06%Amplitude
48.16%Gross Margin
544.98MMarket Cap
-2.00Reward/Risk
3.36%Risk Rate

Key Insights

Cytek Biosciences Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 85 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.69.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Cytek Biosciences Inc's Score

Industry at a Glance

Industry Ranking
85 / 199
Overall Ranking
173 / 4281
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Cytek Biosciences Inc Highlights

StrengthsRisks
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 201.49M.
Overvalued
The company’s latest PE is -7.29, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 84.13M shares, decreasing 7.74% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 1.80M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.15.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
5.688
Target Price
+34.77%
Upside Space

Cytek Biosciences Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 4 analysts
Buy
Current Rating
5.688
Target Price
+34.77%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Cytek Biosciences Inc
CTKB
4
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18

Indicators

Indicators
Sell(2)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.105
Neutral
RSI(14)
39.715
Neutral
STOCH(KDJ)(9,3,3)
15.677
Oversold
ATR(14)
0.171
Low Volatility
CCI(14)
-197.895
Sell
Williams %R
87.121
Oversold
TRIX(12,20)
0.121
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
4.356
Sell
MA10
4.449
Sell
MA20
4.515
Sell
MA50
4.286
Sell
MA100
4.338
Sell
MA200
4.573
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Cytek Biosciences Inc Info

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
Ticker SymbolCTKB
CompanyCytek Biosciences Inc
CEOJiang (Wenbin)
Websitehttps://cytekbio.com

Shareholders

Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
12.28%
Topline Capital Management, LLC
5.76%
HHLR Advisors, Ltd.
5.15%
Millennium Management LLC
5.14%
Boston Partners
4.49%
Other
67.17%

FAQs

What is the current price of Cytek Biosciences Inc (CTKB)?

The current price of Cytek Biosciences Inc (CTKB) is 4.22.

What is the symbol of Cytek Biosciences Inc?

The ticker symbol of Cytek Biosciences Inc is CTKB.

What is the 52-week high of Cytek Biosciences Inc?

The 52-week high of Cytek Biosciences Inc is 6.18.

What is the 52-week low of Cytek Biosciences Inc?

The 52-week low of Cytek Biosciences Inc is 2.46.

What is the market capitalization of Cytek Biosciences Inc?

The market capitalization of Cytek Biosciences Inc is 544.98M.

Is Cytek Biosciences Inc (CTKB) currently rated as Buy, Hold, or Sell?

According to analysts, Cytek Biosciences Inc (CTKB) has an overall rating of Buy, with a price target of 5.69.

What is the Earnings Per Share (EPS TTM) of Cytek Biosciences Inc (CTKB)?

The Earnings Per Share (EPS TTM) of Cytek Biosciences Inc (CTKB) is -0.52.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.